학술논문

TROP2 expression and SN38 antitumor activity in malignant pleural mesothelioma cells provide a rationale for antibody-drug conjugate therapy
Document Type
Article
Source
In: Lung Cancer. (Lung Cancer, April 2023, 178:237-246)
Subject
Language
English
ISSN
18728332
01695002